Šveits - saksa - Swissmedic (Swiss Agency for Therapeutic Products)

wala schweiz ag - cornea bovis gl d6 (hab 41c), corpus vitreum bovis gl d6 (hab 41b), lens cristallina bovis gl d6 (hab 41b), levisticum officinale e radice rec. ferm 33c d5 (hab 33c), nervus opticus bovis gl d5 (hab 41a), quercus robur/petraea e cortice cum calcio carbonico d 12 (hab 5b) (factus ex: quercus robur/petraea e cortice, decoctum tm (hab 23a) potentiae cum calcium carbonicum e cinere quercus corticis solutum), rosae aetheroleum d7 (hab 5a) - augentropfen - cornea bovis gl d6 (hab 41c) 100 mg, corpus vitreum bovis gl d6 (hab 41b) 100 mg, lens cristallina bovis gl d6 (hab 41b) 100 mg, levisticum officinale e radice rec. ferm 33c d5 (hab 33c) 100 mg, nervus opticus bovis gl d5 (hab 41a) 100 mg, quercus robur/petraea e cortice cum calcio carbonico d 12 (hab 5b) (factus ex: quercus robur/petraea e cortice, decoctum tm (hab 23a) potentiae cum calcium carbonicum e cinere quercus corticis solutum) 100 mg, rosae aetheroleum d7 (hab 5a) 100 mg, natrii chloridum, natrii hydrogenocarbonas, aqua ad iniectabile, ad solutionem pro 1 ml, corresp. 33 guttae. - zulassung mit reduziertem dossier ohne indikation nach art. 25 abs. 1 kpav (sr 812.212.24) - anthroposophische arzneimittel

Iirimaa - inglise - HPRA (Health Products Regulatory Authority)

b. braun medical limited - dipotassium phosphate ; potassium dihydrogen phosphate - concentrate for solution for infusion - 1mmol/ml + 0.6 millimole(s)/millilitre - electrolyte solutions; potassium phosphate, incl. combinations with other potassium salts

Šveits - itaalia - Swissmedic (Swiss Agency for Therapeutic Products)

wala schweiz ag - cornea bovis gl d6 (hab 41c), corpus vitreum bovis gl d6 (hab 41b), lens cristallina bovis gl d6 (hab 41b), levisticum officinale e radice rec. ferm 33c d5 (hab 33c), nervus opticus bovis gl d5 (hab 41a), quercus robur/petraea e cortice cum calcio carbonico d 12 (hab 5b) (factus ex: quercus robur/petraea e cortice, decoctum tm (hab 23a) potentiae cum calcium carbonicum e cinere quercus corticis solutum), rosae aetheroleum d7 (hab 5a) - collirio - cornea bovis gl d6 (hab 41c) 100 mg, corpus vitreum bovis gl d6 (hab 41b) 100 mg, lens cristallina bovis gl d6 (hab 41b) 100 mg, levisticum officinale e radice rec. ferm 33c d5 (hab 33c) 100 mg, nervus opticus bovis gl d5 (hab 41a) 100 mg, quercus robur/petraea e cortice cum calcio carbonico d 12 (hab 5b) (factus ex: quercus robur/petraea e cortice, decoctum tm (hab 23a) potentiae cum calcium carbonicum e cinere quercus corticis solutum) 100 mg, rosae aetheroleum d7 (hab 5a) 100 mg, natrii chloridum, natrii hydrogenocarbonas, aqua ad iniectabile, ad solutionem pro 1 ml, corresp. 33 guttae. - zulassung mit reduziertem dossier ohne indikation nach art. 25 abs. 1 kpav (sr 812.212.24) - antroposofici

Euroopa Liit - inglise - EMA (European Medicines Agency)

holostem s.r.l - ex vivo expanded autologous human corneal epithelial cells containing stem cells - stem cell transplantation; corneal diseases - ophthalmologicals - treatment of adult patients with moderate to severe limbal stem cell deficiency (defined by the presence of superficial corneal neovascularisation in at least two corneal quadrants, with central corneal involvement, and severely impaired visual acuity), unilateral or bilateral, due to physical or chemical ocular burns. a minimum of 1-2 mm2 of undamaged limbus is required for biopsy.

Austraalia - inglise - Department of Health (Therapeutic Goods Administration)

queensland eye bank - cornea -

Saksamaa - saksa - BfArM (Bundesinstitut für Arzneimittel und Medizinprodukte)

vitorgan arzneimittel gmbh (3091581) - anwendung am auge; anwendung am auge; anwendung am auge; anwendung am auge; cornea bovis fetalis (pot.-angaben); placenta materna bovis (pot.-angaben); tunica conjunctiva bovis fetalis (pot.-angaben); tunica mucosa naso-pharyngeal bovis (pot.-angaben); glandula thymi bovis fetalis (pot.-angaben); lien bovis fetalis (pot.-angaben); nodus lymphaticus bovis fetalis (pot.-angaben); glandula suprarenalis bovis (pot.-angaben); retina bovis fetalis (pot.-angaben); chorioidea bovis fetalis (pot.-angaben); nervus op - augentropfen - anwendung am auge (hund) - -; anwendung am auge (katze) - -; anwendung am auge (pferd) - -; anwendung am auge (ziervogel) - -; cornea bovis fetalis (pot.-angaben) (11441) information nicht vorhanden; placenta materna bovis (pot.-angaben) (11873) information nicht vorhanden; tunica conjunctiva bovis fetalis (pot.-angaben) (11198) information nicht vorhanden; tunica mucosa naso-pharyngeal bovis (pot.-angaben) (20263) information nicht vorhanden; glandula thymi bovis fetalis (pot.-angaben) (20253) information nicht vorhanden; lien bovis fetalis (pot.-angaben) (14215) information nicht vorhanden; nodus lymphaticus bovis fetalis (pot.-angaben) (15072) information nicht vorhanden; glandula suprarenalis bovis (pot.-angaben) (15081) information nicht vorhanden; retina bovis fetalis (pot.-angaben) (36965) information nicht vorhanden; chorioidea bovis fetalis (pot.-angaben) (36966) information nicht vorhanden; nervus opticus bovis fetalis (pot.-angaben) (36967) information nicht vorhanden; lens cristallina bovis (pot.-

Euroopa Liit - portugali - EMA (European Medicines Agency)

holostem s.r.l - células epiteliais corneanas humanas autólogas expandidas ex vivo que contêm células estaminais - stem cell transplantation; corneal diseases - oftalmológicos - tratamento de pacientes adultos com deficiência de células estaminais limbo moderadas a graves (definidos pela presença de neovascularização corneana superficial em pelo menos dois quadrantes corneanos, com comprometimento corneano central e gravidade visual severa), unilateral ou bilateral, devido a ocular física ou química queima. um mínimo de 1-2 mm2 de limbo não danificado é necessário para biópsia.

Euroopa Liit - hispaania - EMA (European Medicines Agency)

holostem s.r.l - células epiteliales corneales humanas autólogas expandidas ex vivo que contienen células madre - stem cell transplantation; corneal diseases - oftalmológicos - tratamiento de pacientes adultos con moderada a severa límbica (definido por la presencia de neovascularización corneal superficial en al menos dos cuadrantes corneales, con afectación corneal central y deterioró severamente la agudeza visual), unilateral o bilateral, debido a las quemaduras oculares químicas o físicas. se requiere un mínimo de 1-2 mm2 de limbo no dañado para la biopsia.

Austraalia - inglise - Department of Health (Therapeutic Goods Administration)

alcon laboratories australia pty ltd - 18038 - corneal topography system - corneal topographer for measuring and generating high resolution treatment data of the corneal surface. this topography system may also be used to directly influence the performance of the laser in topography guided laser refractive surgeries.

Austraalia - inglise - Department of Health (Therapeutic Goods Administration)

bausch & lomb australia pty ltd - 37896 - corneal marker - corneal markers are used to mark the corneal epithelium for various types of incisions in corneal surgery. this is a reusable device.